Anti-idiotype hepatitis B vaccine - AltaRexAlternative Names: Foreign antibody-based therapeutic hepatitis B vaccine - AltaRex
Latest Information Update: 26 Jun 2002
At a glance
- Originator AltaRex
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 26 Jun 2002 Discontinued - Preclinical for Hepatitis B treatment in USA (unspecified route)
- 15 Feb 2001 Preclinical development for Hepatitis B treatment in USA (Unknown route)